Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16397521 | 0.85 | MAPT (0.48) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL7066 | 0.83 | CYP2C9 (0.74) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL4823051 | 0.81 | CYP2C9 (0.65) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL1680669 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL9568239 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL1681667 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL5705762 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL11049826 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL20957595 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 | |
| Benzylic Acid SCHEMBL9181980 | 0.81 | CYP2C9 (0.71) | CYP2C9CYP2D6HIF1ACYP1A2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114214009-A | High-temperature-resistant antistatic pressure-sensitive adhesive and application thereof | 襄阳三沃航天薄膜材料有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-117378314-B | Ecological restoration method for coal mine area | 中国科学院西北高原生物研究所 | 2025-05-13 | — | — | CN | disclosed |
| EP-3148518-B1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PRIVATE LTD (IN) | 2022-11-30 | — | — | EP | disclosed |
| CN-115108901-A | Synthetic method of alpha-hydroxycarboxylic acid compound | 四川大学 | 2022-09-27 | — | — | CN | disclosed |
| CN-114214009-A | High-temperature-resistant antistatic pressure-sensitive adhesive and application thereof | 襄阳三沃航天薄膜材料有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-114214009-A | High-temperature-resistant antistatic pressure-sensitive adhesive and application thereof | 襄阳三沃航天薄膜材料有限公司 | 2022-03-22 | — | — | CN | disclosed |
| CN-108715729-B | Preparation method of flame-retardant antibacterial waterborne polyurethane coating and adhesive | 浙江伟涛包装材料有限公司 | 2021-06-08 | — | — | CN | disclosed |
| US-10207993-B2 | Compounds as anti-tubercular agents | SPHAERA PHARMA PVT. LTD. (IN) | 2019-02-19 | — | — | US | disclosed |
| US-10100012-B2 | Compounds as anti-tubercular agents | SPHAERA PHARMA PVT. LTD. (IN) | 2018-10-16 | — | — | US | disclosed |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PVT. LTD. (IN) | 2017-11-23 | — | — | US | disclosed |
| US-7723356-B2 | Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists | NOVARTIS AG (CH) | 2010-05-25 | — | — | US | disclosed |
| US-20090155185-A1 | MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC | MEADE CHRISTOPHER JOHN MONTAGUE | 2009-06-18 | — | — | US | disclosed |
| US-20090048281-A1 | (R)-3-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-1-(isoxazol-3-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2] octane, useful for treating inflammatory or obstructive airways diseases | NOVARTIS AG (CH) | 2009-02-19 | — | — | US | disclosed |
| CN-101056634-A | Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists | NOVARTIS AG (CH) | 2007-10-17 | — | — | CN | disclosed |
| EP-1811999-A1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | Novartis AG (CH) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006048225-A1 | QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 2006-05-11 | — | — | WO | disclosed |
| US-20050025718-A1 | Medicaments for inhalation comprising an anticholinergic and a betamimetic | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-02-03 | — | — | US | disclosed |
| US-6696462-B2 | CYCLOPROPYLTROPINE CARBOXYLATE DERIVATIVES | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-02-24 | — | — | US | disclosed |
| US-20030207912-A1 | Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH. CO. KG (DE) | 2003-11-06 | — | — | US | disclosed |
| EP-0894797-A1 | NOVEL AMIDE DERIVATIVES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF | TERUMO KABUSHIKI KAISHA (JP) | 1999-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10100012-B2 | Compounds as anti-tubercular agents | FNTB, G6PD, PGGT1B | CYP2C9 1403/4885CYP2D6 865/4885HIF1A 3155/4885 |
| US-10207993-B2 | Compounds as anti-tubercular agents | FNTB, G6PD, PGGT1B | CYP2C9 1403/4885CYP2D6 865/4885HIF1A 3155/4885 |
| US-20090048281-A1 | (R)-3-(2-Cyclohexyl-2-hydroxy-2-phenyl-acetoxy)-1-(isoxazol-3-ylcarbamoylmethyl)-1-azonia-bicyclo[2.2.2] octane, useful for treating inflammatory or obstructive airways diseases | CHRM3, CHRM2, CHRM1 | CYP2C9 1533/4885CYP2D6 2336/4885HIF1A 1651/4885 |
| US-20090155185-A1 | MEDICAMENTS FOR INHALATION COMPRISING AN ANTICHOLINERGIC AND A BETAMIMETIC | ADRB2, CHRM3, ADRB1 | CYP2C9 1107/4885CYP2D6 280/4885HIF1A 1874/4885 |
| US-20030207912-A1 | Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions | CHRM1, CHRNA1, CHRNB1 | CYP2C9 668/4885CYP2D6 493/4885HIF1A 2301/4885 |
| US-20170334851-A1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | FNTB, PGGT1B, GGPS1 | CYP2C9 2844/4885CYP2D6 1722/4885HIF1A 3358/4885 |
| US-20050025718-A1 | Medicaments for inhalation comprising an anticholinergic and a betamimetic | ADRB2, CHRM3, ADRB1 | CYP2C9 1107/4885CYP2D6 280/4885HIF1A 1874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.